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Abstract
Background:  Myofibroblasts, proposed as being derived from circulating fibrocytes, are
considered to be important cells in thickening of the basement membrane in patients with asthma.
We have studied the correlation of tissue fibrocyte levels to basement membrane thickness and
the presence of fibrocytes in bronchoalveolar lavage fluid (BALF) in steroid-naive patients with mild
asthma and controls.
Methods: Patients with mild asthma (n = 9) were recruited and divided into two categories based
on whether or not fibroblast-like cells could be established from BALF. Non-asthmatic healthy
subjects (n = 5) were used as controls. Colocalization of the fibrocyte markers CD34, CD45RO,
procollagen I, and α-smooth muscle actin (α-SMA) were identified in bronchial biopsies from
patients and controls by confocal microscopy. Kruskall-Wallis method was used to calculate
statistical significance and Spearman coefficient of rank correlation was used to assess the degree
of association.
Results: In patients with BALF fibroblasts, a 14-fold increase of tissue cells expressing CD34/
CD45RO/α-SMA and a 16-fold increase of tissue cells expressing CD34/procollagen I was
observed when compared to controls (p < 0.05). In contrast, patients without BALF fibroblasts
displayed a 2-fold increase when compared to controls (p < 0.05). Fibrocytes were localized close
to the basement membrane which was significantly thicker in patients with BALF fibroblasts when
compared to the other two groups of subjects. Furthermore, basement membrane thickness could
be correlated to the number of fibrocytes in tissue (r = 0.711). Fibroblasts-like cells were cultured
from BALF where 17.6% of these cells expressed CD34, CD45RO and α-SMA.
Conclusion: These findings indicate a correlation between recruited fibrocytes in tissue and
thickness of basement membrane. Fibroblast progenitor cells may therefore be important in airway
remodeling in steroid-naive patients with mild asthma.
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Background
Asthma is characterized by airway inflammation and
structural remodeling of the lung [1]. These processes may
result in sub-epithelial fibrosis that leads to thickening of
the lamina reticularis, which contains an increased
amount of connective tissue components such as colla-
gens, tenascin, fibronectin and proteoglycans [2-4].
Fibroblasts are considered to be important key cells in this
mechanism since they migrate to sites of injury where they
acquire a myofibroblast phenotype, upon activation by
factors such as TGF-β1, which is followed by production
of a new extracellular matrix [5,6]. However, considering
the importance of fibroblasts in airway remodeling it is
important to establish the possible origins of these cells
which today are unclear. It has been postulated in several
in vivo models and in patients with allergen-induced
asthma that lung tissue repair and regeneration after
injury involve the selective recruitment of circulating
fibroblast progenitor cells, termed fibrocytes [7-9]. These
cells comprise a minor component (<1%) of the circulat-
ing pool of leukocytes and have been characterized as
antigen presenting cells, which express a specific pattern
of both mesenchymal and hematopoetic markers includ-
ing procollagen I, alpha-smooth muscle actin (α-SMA),
CXCR4, CD34, and CD45RO [10]. Fibrocytes have been
shown to be important in the generation of fibrosis in sev-
eral in vivo models where inhibition of fibrocyte recruit-
ment leads to a decrease of fibrotic tissue [11-13].
Furthermore, TGF-β1 is an important inducer of fibrosis
and may in addition stimulate fibroblasts in tissue and
induce the differentiation of fibrocytes into myofibrob-
last-like cells with elevated production of extracellular
matrix components [14,15]. Although these findings sug-
gest that fibrocytes are important key cells in airway
remodeling in patients with allergen-induced asthma and
in vivo models, fibrocytes have not been studied in ster-
oid-naive patients with mild asthma.
We have previously shown that activated fibroblasts-like
cells may be cultured from bronchoalveolar lavage fluid
(BALF) from a sub-group of patients with mild asthma
accompanied by elevated levels of eosinophils [16]. These
BALF fibroblasts could originate from circulating progen-
itor cells, such as fibrocytes, which may differentiate into
myofibroblast-like cells. We hypothesized therefore if
fibrocytes were present in remodeled lung tissue and BALF
from steroid-naive patients with mild asthma and, if so,
correlated with a thickened basement membrane.
Methods
Subjects, bronchoalveolar lavage and sampling of lung 
tissue
Patients (n = 9) suffering from mild asthma and definite
bronchial hyperresponsiveness were included in the
study, reviewed and approved by the Swedish Research
Ethical Committee (LU339-00). These patients were 25–
31 years of age with positive phadiotope staining, non-
smokers, PD20 < 2 mg/ml of methacholine stimulation,
displayed stable mild persistent asthmatic conditions
with normal spirometry baseline, free of infections six
weeks before bronchoscopy, and had no corticosteroid
treatment for six months prior to the study. All of the
patients with asthma were atopic and sensitive to pets (cat
allergy). Five of the patients with asthma had perennial
allergy and one patient had seasonal allergy only (birch
pollen). The patients with asthma were further divided
into two groups based on whether they displayed the pre-
viously described BALF fibroblasts or not (n = 5 and 4,
respectively).
The control subjects used (n = 5) were 24–51 years of age.
These subjects were non-asthmatic healthy volunteers
with a reversibility in FEV1 < 12%, with no allergic symp-
toms, and who did not respond to doses of methacholine
lower than 2 mg/ml. BAL was performed by instillation of
buffered saline solution with a recovery of more than
70%. Bronchial biopsies were taken from the central air-
ways of the right lung and collected as previously
described [17]. Five biopsies were taken from each sub-
ject. The biopsies collected did not show any differences
in size, vascularity, or muscle content. From each individ-
ual 16 sections were analyzed.
Cell cultures and cytospin analysis
Primary fibroblasts-like cells were established from BALF
as previously described [18]. Briefly, BALF was centrifuged
at 500 g for 10 min and the supernatant was discarded and
Fibrocyte markers expressed in the BALF fibroblasts. Table 1
Fibrocyte markers expressed in the BALF fibroblasts. This 
table displays the number of positive cells in passage 3–6 
from BALF fibroblast cultures from patients with mild asthma 
(n = 5) stained for the different fibrocyte markers used in the 
study.Respiratory Research 2006, 7:50 http://respiratory-research.com/content/7/1/50
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the precipitated BALF cells were washed with DMEM. The
precipitated cells were cultured in DMEM supplemented
with 10% Fetal Clone III (Hyclone, UT), 1% L-glutamine,
0.5% gentamicin and 5 µg/ml amfoterracin, until out-
growth of fibroblast-like cells reached confluence (20–30
days). These fibroblast-like cells were characterized by
expression of α-SMA, collagen, and high production of
proteoglycans (16). The cultures were trypsinized and
used in passage 4–7. Cytospin was performed using a
cytocentrifuge (Shandon Southern Products Ltd, Run-
corn, Cheshire, UK) where cells in the BALF were col-
lected. The cells were stained using the May-Grünwald/
Giemsa (Sigma Aldrich, Stockholm, Sweden) method
according to instructions from the manufacturer. 200 cells
were counted and granulocytes were identified according
to their morphological structure.
Histological studies and measurement of basement 
membrane thickness
Bronchial biopsies were fixed in 4% paraformaldehyd,
embedded in paraffin and sectioned (5 µm). Basic mor-
phological characterization was made using Gomoris Tri-
chrome staining kit (Polysciences Inc, Warrington, PA) for
staining of nuclei, muscles fibers and collagen I. Photo-
graphs were taken using a light microscope camera (DM
IRB, Leica, Wetzlar, Germany).
Basement membrane thickness was quantified by measur-
ing the area of the entire basement membrane, from the
base of the bronchial epithelium to the outer limit of the
lamina reticularis, and the length of the true basement
membrane. This was performed using a computerized
image (Leica Software Q500IW, Leica, Wetzlar, Ger-
many).
Thickness was calculated as area/length of the basement
membrane. These measurements were performed as pre-
viously described [19].
Confocal microscopy
Embedded and fixed tissue sections (5 µm) and cultured
BALF fibroblasts were dehydrated and incubated with pri-
mary monoclonal mouse anti-human antibodies: CD34,
CD45RO (BD Biosciences, Pharmingen, Leiden, The
Netherlands) and α-SMA with Cy3 conjugates (Sigma
Aldrich, Stockholm, Sweden). For cultured BALF fibrob-
last, cells were fixed in 4% paraformaldehyde and 0.5%
Triton X-100 in PBS was used as a permeabilization agent
prior  α-SMA staining. Secondary antibodies used for
detection of CD34 and CD45RO were Alexa Fluor 488
and 647 (Molecular Probes, Eugene, OR), respectively.
CD45RO and prolyl-4-hydroxylase detection; fixed tissue
sections were dehydrated, treated with 1% trypsin, cov-
ered with blocking solution (PBS containing 3%BSA, 5%
fatfree milkpowder, and 1% goat serum) and incubated
with primary monoclonal antibody CD45RO (BD Bio-
sciences, Pharmingen, Leiden, The Netherlands), prolyl-4-
hydroxylase (Dakocytomation, Denmark) and nucleic
staining (Sytox Blue Nucleic Acid Stain, Molecular Probes,
Eugene, OR). Sections were then washed with TBS+0.5%
Triton X. Secondary antibodies used for detection of
CD45RO and prolyl-4-hydroxylase were Alexa Flour 488
and 647 (Molecular Probes, Eugene, OR), respectively.
For CD34 and procollagen I detection; fixed tissue sec-
tions were dehydrated, treated with 1% trypsin, covered
with blocking solution (PBS containing 3%BSA, 5% fat-
free milk powder, and 1% goat serum) and incubated
with primary antibody mouse anti-human CD34 (BD
Biosciences, Pharmingen, Leiden, The Netherlands), rat
anti-human procollagen I (Chemicon, Europe Ltd, Hamp-
shire, United Kingdom and nucleic staining (Sytox Blue
Nucleic Acid Stain, Molecular Probes, Eugene, OR). Sec-
Criteria used when counting fibrocytes in bronchial biopsies Figure 1
Criteria used when counting fibrocytes in bronchial biopsies. 
Sections from patients and controls were based on an intact 
basement membrane together with intact tissue of at least 70 
µm in every section. Area A starts were the basement mem-
brane ends. A = 0–70 µm in the section. B = 71–140 µm in 
the section and C = 141–210 µm in the tissue. Definition of 
abbreviations: BM = Basement membrane, E = epithelium, MF 
= Muscle fibers.Respiratory Research 2006, 7:50 http://respiratory-research.com/content/7/1/50
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tions were then wash with TBS+0.5% Triton X and
blocked with 10% goat serum (Vector Laboratories, Burl-
ingame, CA, USA) in PBS. Secondary antibodies used for
detection of CD34 and procollagen I were Alexa Flour 488
and 633 (Molecular Probes, Eugene, OR), respectively.
Control experiments were performed with/without pri-
mary antibody or with/without secondary antibody. Con-
trol sections were included in all experiments to correct
for background fluorescence. Isotype controls were used
in combination and for each fluorochrome to decrease
the risk of detecting unspecific staining. Fibrocytes were
counted in a subepithelial zone 0–210 µm deep into the
reticular zone and divided into area A, B and C (each area
70 µm deep). Results were expressed as the number of
cells per 1 mm2. All sections with an intact basement
membrane and a minimum requirement of intact tissue
70 µm into the reticular zone were counted. Sections were
analyzed with Leica confocal-scanning equipment TCS
SP2 II (Leica, Wetzlar, Germany).
Quantification of fibrocytes in cultured BALF fibroblasts
BALF fibroblasts (5000 cells) were cultured 48 h in 4 well
chambers. Thereafter 200 cells were randomly choosed
for cell counting for their different markers for fibrocytes
differentiation.
Statistical analysis
Mean values ± standard errors of the mean (SEM) were
calculated and Kruskall-Wallis was used for analyses of
statistical significance (SPSS v7.0, Chicago, IL). All values
of p < 0.05 were considered significant. Spearman coeffi-
cient of rank correlation was used to assess the degree of
association between basement membrane thickness and
number of fibrocytes.
Results
Tissue fibrocytes are localized in proximity to the 
basement membrane in patients with mild asthma
The sub-epithelial bronchial tissues were divided into
three sections (A, B, and C) when studying the localiza-
tion of fibrocytes (Figure 1). The presence of double
stained cells could be analyzed by using antibodies for
CD34/α-SMA (Figure 2A), CD45RO/α-SMA (Figure 2B),
CD34/CD45RO (Figure 2C), and analyzed by confocal
microscope. The indication of a fibrocytes phenotype
could be demonstrated by colocalization of all these three
markers (Figure 2D). Fibrocytes were primarily localized
individually and in clusters close to the epithelium and to
blood vessels (Figure 2E). Limited background staining
was seen throughout the confocal analysis, indicating spe-
cificity for the antibodies used (Figure 2F). Single positive
cells were also detected close to triple positive cells in the
basement membrane proximity.
Apart from expressing CD34/CD45RO, fibrocytes are fur-
ther characterized as being collagen producing cells. The
cells were therefore stained for prolyl-4-hydroxylase, a
protein critically involved in collagen synthesis, and pro-
collagen I. Prolyl-4-hydroxylase/CD45RO could be seen
Fibrocytes are localized in proximity to the basement mem- brane in patients with mild asthma Figure 2
Fibrocytes are localized in proximity to the basement mem-
brane in patients with mild asthma. Bronchial biopsies were 
stained using immunofluorescent antibodies against 
CD34(green), α-SMA(blue), CD45RO(red), and were sub-
jected to confocal microscopy. Cells coexpressing CD34/α-
SMA (A), CD45RO/α-SMA (B), and CD34/CD45RO (C) is 
presented where the merged pictures show double positive 
stained cells. Squares indicate the same area in one tissue 
section of double and triple positive cells close to the base-
ment membrane. A merged picture illustrating the expres-
sion of all antibodies is presented (D) and a transmission 
picture shows localization of stained cells in tissue (E). Con-
trol staining indicates insignificant background staining in con-
focal and transmission mode (G). Definition of abbreviations: 
BM = Basement membrane, BV = Blood vessel, E = Epithe-
lium.Respiratory Research 2006, 7:50 http://respiratory-research.com/content/7/1/50
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in separate cells and in clusters of cells (Figure 3A). These
two markers were also colocalized as shown by a merged
picture. The cells did also stain procollagen I/CD34 and
the merged picture indicate coexpression of these markers
(Figure 3B). Collectively, the merged pictures illustrate
positive cells for these markers suggesting an active colla-
gen production in these fibrocytes.
When counting number of fibrocytes in the tissue,
patients with BALF fibroblasts displayed a 14-fold
increase (p < 0.01) in the total number of triple positive
CD34/CD45RO/α-SMA fibrocytes present in area A + B
when compared to controls (Figure 4A). The other patient
group without fibroblasts in BALF displayed a significant
2-fold increase (p < 0.05) in fibrocytes when compared to
controls. The localization of triple positive cells strongly
suggests a gradient of fibrocytes present throughout these
areas. In area A, patients with BALF fibroblasts displayed
an 11-fold increase of fibrocytes (p < 0.05) when com-
pared to controls (52 ± 32 vs. 5 ± 2) and a 5-fold increase
when compared to patients without BALF fibroblasts (52
± 32 vs. 12 ± 1). This pattern was similar in area B where
fibrocytes were observed in patients with and without
BALF fibroblasts (11 ± 6 vs. 4 ± 2) but not in the controls.
In area C, fibrocytes were only detected in patients with
BALF fibroblasts (3 ± 1) and controls (1 ± 1). When quan-
tifying the number of prolyl-4-hydroxylase/CD45RO pos-
itive cells, patients with BALF fibroblasts showed 2.5-fold
elevated levels of these cells when compared to the other
patient group (p < 0.05) and 17-fold increase when com-
pared to controls (p < 0.05) (Figure 4B). A similar pattern
was seen when quantifying CD34/procollagen I positive
cells (Figure 4C), where a 2-fold increase (p < 0.05) in
double positive cells were seen in patients with BALF
fibroblasts when compared to the other patient group and
a 16-fold increase when compared to controls (p < 0.05).
Fibrocytes levels correlate to thickness of basement 
membrane
The basement membrane thickness was measured in con-
trols (Figure 5A), patients with asthma with BALF fibrob-
lasts (Figure 5B), and patients without BALF fibroblasts
(Figure 5C). The basement membrane was significantly
thicker in patients with asthma with BALF fibroblast (7.95
± 0.98 µm) when compared to the other patient group
and controls (6.12 ± 0.18 µm and 5.23 ± 0.4 µm respec-
tively, p < 0.05) (Figure 5D). A higher number of cells
detected by hematoxylin staining beneath the basement
membrane when compared to controls were characteristic
for both groups of patients. Moreover, our data indicate a
correlation between thickness of basement membrane
and the presence of fibrocytes in the tissue of controls and
patients with asthma (r = 0.711) (Figure 5E).
BALF fibroblasts display fibrocyte characteristics
BALF fibroblasts displayed an elongated, spindle-like
shape after 20–30 days in culture (Figure 6A). So far, the
origin of cultured BALF fibroblasts from patients with
mild asthma has not been studied in detail. To see
whether the BALF fibroblasts displayed characteristics of
Fibrocytes in patients with mild asthma express collagen Figure 3
Fibrocytes in patients with mild asthma express collagen. 
Bronchial biopsies were stained using immunofluorescent 
antibodies against prolyl-4-hydroxylase (green) CD45RO 
(red) and nuclei (blue) (A). Squares indicate the same cluster 
area as shown in A. The merged picture describes the posi-
tive cells within the square. Cells were further stained for 
CD34 (green), procollagen I (red), and nuclei (blue) (B), and 
were subjected to confocal microscopy. The merged picture 
describes the positive cell within the square. Definition of 
abbreviations: BM = Basement membraneRespiratory Research 2006, 7:50 http://respiratory-research.com/content/7/1/50
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fibrocytes, these cells were triple-stained for CD34,
CD45RO, and α-SMA, and subjected to confocal micros-
copy. Again, insignificant levels of background staining
were seen indicating specificity for the antibodies used
(data not shown). The BALF fibroblasts did indeed express
the fibrocyte markers CD34, CD45RO, and α-SMA, which
suggest that these cells may be derived from fibrocytes
(Figure 6B). The number of BALF fibroblasts in passage 3–
6 expressing all three fibrocyte markers constituted one
fifth of the total cell count. Double-positive cells express-
ing CD34/α-SMA or CD45RO/α-SMA constituted 11.7 %
and 5% respectively (Table 1 - figure 7). Moreover, 41 %
of the cells stained positive only for α-SMA.
Inflammatory cells such as eosinophils are suggested to be
important in mediating the airway inflammation in
patients with asthma and in vivo models [1,20]. Increased
levels of BALF eosinophils have been reported in patients
with BALF fibroblasts, which suggests an active inflamma-
tory link to the presence of these fibroblasts [21]. How-
ever, we did not observe any correlation between the
number of BALF eosinophils and fibrocytes in lung tissue
from patients with mild asthma in this study (data not
shown).
Discussion
This is the first study to report an increased number of
fibrocytes expressing CD34/CD45RO/α-SMA/procolla-
gen I, and a localization of these cells to areas close to the
basement membrane in steroid-naive patients with mild
asthma when compared to controls. The inclusion of α-
SMA coexpression to the other fibrocyte markers may
indicate a possible link between circulating progenitor
cells and their potential differentiation into α-SMA
expressing myofibroblasts in these patients. It should be
noted that the patients included in this study is very
homogenous since they did not show any distinct clinical
patterns except for five patients that had perennial allergy
and were sensitive to cat.
Fibrocyte levels correlated to the thickness of the base-
ment membrane proposing that these cells may partici-
pate in airway wall remodeling. The relative high levels of
fibrocytes expressing α-SMA seen in patients with
increased basement membrane thickness may indicate a
more differentiated fibrocyte phenotype that is similar to
the myofibroblast. In contrast to our findings, Schmidt
and coworkers reported higher levels of collagen I express-
ing cells than α-SMA positive cells in ovalbumin treated
mice and patients with allergen-provoked asthma [22].
Apart from the different study models used, these differ-
ences may be caused by alteration in cell differentiation
which is difficult to monitor for fibrocytes in particular.
Importantly, the analysis of prolyl-4-hydroxylase in our
study indicates an active collagen production in the
reported fibrocytes.
To our knowledge, this is the first study to report a corre-
lation between tissue fibrocytes and increased thickness of
basement membrane. Thickening of the lamina reticularis
has been reported in the airways of children with severe
asthma and has been shown to correlate to airway hyper-
responsiveness, as well as an increased number of fibrob-
lasts and myofibroblast in this area [23-25]. Apart from
Quantification of CD34, CD45RO, α-SMA, procollagen I and  prolyl-4-hydroxylase coexpression in fibrocytes Figure 4
Quantification of CD34, CD45RO, α-SMA, procollagen I and 
prolyl-4-hydroxylase coexpression in fibrocytes. Cells in 
bronchial biopsies coexpressing CD34/CD45RO/α-SMA (A), 
CD45RO/prolyl-4-hydroxylase (B), and CD34/procollagen I 
(C), were counted. These cells were counted in the areas A 
and B and data included are from controls, patient with mild 
asthma with (+) and without (-) BALF fibroblasts and are pre-
sented as positive cells/mm2 of tissue section. Values are pre-
sented as means ± SEM, n = 4–5 patients.Respiratory Research 2006, 7:50 http://respiratory-research.com/content/7/1/50
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the differentiation of fibrocytes into myofibroblasts-like
cells, additional sources of myofibroblasts, that may con-
tribute to the enhanced extracellular matrix deposition
during pathological conditions include resident myofi-
broblasts, differentiation of bronchial muscle cells and
epithelial mesenchymal transition [26,27].
Molecules secreted by airway epithelium and surrounding
inflammatory cells may explain the observed difference in
numbers of fibrocytes in area A compared to area B and C.
Factors that have previously been shown to be involved in
the recruitment of fibrocytes to the fibrotic tissue include
IL-1β, ED-A fibronectin, stromal-derived factor 1 (SDF1/
CXCL12), granulocyte macrophage stimulating-factor
(GM-CSF). Hence, the differentiated levels of fibrocytes
and basement membrane thickness seen in this study may
be a result of an altered local environment in the lungs of
the two sub-groups of patients with mild asthma. Future
screening of fibrocyte recruiting molecules in the BALF
from these patients could provide a better understanding
of the differences observed.
The outgrowth of fibroblasts in BALF from a sub-group of
patients with mild asthma indicate a possible origin from
circulating fibroblast progenitor cells, due to their relative
high expression of fibrocyte markers CD34, CD45RO and
α-SMA. Since the airway lumen has low levels of extracel-
lular matrix, which is a prerequisite for survival of mature
fibroblast, it is very likely that the BALF fibroblasts are
derived from circulating fibrocytes rather than the resid-
ing tissue fibroblast pool. These lumen-derived cells were
seen to correlate to the number of tissue fibrocytes and
basement membrane thickness, indicating a possible link
to the pathological changes in these patients.
When human fibrocytes are cultured in vitro, a decrease in
the expression of CD34 and CD45RO occurs in parallel
with an increased expression of α-SMA. This may confirm
why one third of the original fibrocytes stained positive
for α-SMA after three weeks. Similarly, approximately 50
% of the cells were stained positive only for α-SMA in pas-
sage 3–6 (Table 1). In the same passages, triple positive
cells constituted approximately a fifth of the total cell
count and double-positive for CD34/α-SMA or CD45RO/
α-SMA constituted 10 % and 5 % respectively. This allow
us to speculate that a homogenous population of CD34/
CD45RO expressing fibrocytes in the BALF may have been
the starting population, which has gradually differenti-
ated into α-SMA expressing myofibroblast-like cells.
Future studies, including detailed analysis of recovered
cells expressing fibrocyte specific markers in BALF, may
provide a clearer future view into this field.
BALF fibroblasts have previously been characterized as
motile cells with a relatively high production of extracel-
lular matrix components, including collagen and prote-
oglycans, accompanied by elevated levels of BALF
eosinophils. In the present study, we did not observe any
correlation of neither BALF nor tissue eosinophils to the
number of fibrocytes in tissue. A possible explanation is
that BALF eosinophils affect the differentiation of fibro-
cytes into myofibroblast-like cells due to their capacity of
secreting TGF-β, rather than the recruitment of these cells
to the lumen. In addition, we have preliminary data indi-
cating a correlation between BALF neutrophils and tissue
fibrocytes, suggesting an alternative inflammatory link to
the recruitment of fibrocytes to the tissue (unpublished
observation).
Basement membrane thickness in patients with mild asthma  and controls Figure 5
Basement membrane thickness in patients with mild asthma 
and controls. Bronchial biopsies from controls (n = 5) (A), 
patients with mild asthma with (+) BALF fibroblasts (n = 5) 
(B) and patients with mild asthma without (-) BALF fibrob-
lasts (n = 4) (C) were stained with Gomoris trichrome stain-
ing for basic morphological characterization. Measurement of 
basement membrane thickness was performed as described 
in the Method section and is presented in µm (D). Number 
of fibrocytes in area A+B were counted and correlated (r = 
0.711) to thickness of basement membrane (µm) (E). Values 
are presented as means ± SEM. Spearman coefficient of rank 
correlation was used to calculate the degree of association 
between basement membrane thickness and number of 
fibrocytes. (▲  patients with BALF fibroblasts, ▪ patients with-
out BALF fibroblasts, ●  controls). Definition of abbreviations: 
BM = Basement membrane, E = epithelium, MF = Muscle fib-
ers.Respiratory Research 2006, 7:50 http://respiratory-research.com/content/7/1/50
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An important question remains to be answered: Do fibro-
cytes differentiate into myofibroblasts, or do they stimu-
late differentiation and proliferation of other progenitor
cells or resident mesenchymal cells within the tissue?
In conclusion, the novel findings that cells from BALF in
patients with mild asthma express fibrocyte specific pro-
teins and the localization in tissue of these cells in close
proximity to a thicker basement membrane emphasize
the importance of these cells in the early stages of remod-
eling and inflammation. Further exploration in patients
with severe asthma would be of paramount interest. The
observation that patients with BALF fibroblasts with fibro-
cyte characteristics are accompanied by a thicker base-
ment membrane suggests a specific pathological process
for these patients when compared to patients lacking
these cells. In the future, modulation of the recruitment
and subsequent differentiation of fibrocytes may there-
fore be of great therapeutic importance in regulating air-
way wall remodeling in asthma.
Conclusion
In conclusion, we hereby show that cells from BALF in
patients with mild asthma express fibrocyte specific pro-
teins and that these are localized in tissue in close proxim-
ity to a thicker basement membrane. These data, together
with recent fibrocyte findings, emphasize the importance
of these cells in airway remodeling in patients with mild
asthma.
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